Option grids in melanoma - an underused tool

It is not uncommon for patients faced with a new diagnosis of malignant melanoma to experience significant upset and confusion. During this distressing period, NICE guidance (NG14) recommends that patients with AJCC Stage IB-IIC disease should consider whether they wish to undergo sentinel lymph node biopsy (SLNB)1. The decision to undergo SLNB can be difficult and should ideally be reached following informed and considered discussion with patients guided as to the relative merits of SLNB by their plastic surgeon.